Clinical Research
corporate_fare

ReproNovo ApS

Address
Amagerfaelledvej 106

Sponsor Overview

assignment
2
sponsored trials
science
0
molecules
location_city
6
research centres
public
2
countries
person_search
6
investigators

Specializations

Reproductive Medicine

ReproNovo ApS focuses on clinical research in assisted reproduction, with particular attention to women undergoing in vitro fertilisation and intracytoplasmic sperm injection. The funded studies are centred on reproductive tract function and treatment-related outcomes relevant to fertility care.

  • IVF and ICSI patient populations
  • Uterine contractility
  • Reproductive pharmacology

Clinical activity in this area reflects interest in therapies intended to support reproductive procedures and improve understanding of uterine response in fertility settings.

Pharmacokinetics and Drug Safety

The sponsor also supports research on the pharmacokinetics and safety of nolasiban, with attention to how the compound behaves in the body and its tolerability profile in human subjects.

  • Pharmacokinetic profiling
  • Safety evaluation
  • Healthy volunteer studies

This area links early clinical development with reproductive indications and supports the assessment of treatment suitability in fertility-related care.

Pharmacodynamics and Uterine Function

Another key area of interest is the pharmacodynamics of nolasiban, particularly its effect on uterine motility and related physiological responses. The research addresses how different treatment regimens influence reproductive tract activity.

  • Uterine motility
  • Treatment response in fertility medicine
  • Reproductive system physiology

These studies are aligned with therapeutic development in women's health and reproductive care, where modulation of uterine activity is clinically relevant.

Sponsored Trials

Trial Name Country Status
A Phase I Study to Evaluate the Pharmacokinetics and Safety of Nolasiban in Healthy VolunteersCzechia CzechiaRecruiting
A Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Effects of Nolasiban Dosing Regimens on Uterine Contractility and Endocrine Parameters in Women Undergoing IVF/ICSISpain SpainRecruiting

Data & Insights

science
Molecule Portfolio
Compounds under investigation
0
Exclusive Molecules
out of 0 total (0% not shared with other sponsors)

This sponsor works with 0 molecules, of which 0 are not being studied by other sponsors.

hub
Site Partnerships
Collaboration with research centres
0%
Return partnership rate
0 of 6 sites collaborated multiple times

This sponsor has worked with 6 sites across their trial portfolio.

Therapeutic Focus

  • 1.
    Female Urogenital Diseases and Pregnancy Complications2 trials
    142 other sponsors

Partnered Research Centres

6 centres
location_city
assignment5
Ginefiv S.L.
Address
Calle De Zurbano 51, 28010 Madrid
Learn morearrow_forward
location_city
assignment3
IVI Barcelona S.L.
Address
Calle Mallorca 45, 08029 Barcelona
Learn morearrow_forward
location_city
assignment1
Ivi Bilbao S.L.
Address
Paseo Landabarri Bidea 1, 48940 Leioa
Learn morearrow_forward
location_city
assignment6
Ivi Madrid S.L.
Address
Avenida Talgo 68-70, 28023 Madrid
Learn morearrow_forward
location_city
assignment6
Ivi Valencia S.L.
Address
Placa Policia Local 3, 46015 Valencia
Learn morearrow_forward
location_city
assignment42
Quinta-Analytica s.r.o.
Address
Prazska 1486/18c, Hostivar, 102 00 Prague
Learn morearrow_forward

Want to get in touch with this sponsor?

Send a question and we'll pass it on to ReproNovo ApS.

Need a custom report on this sponsor?

Competitive positioning, market entry, partnership opportunities — tell us the question.

Is something out of date?

Tell us what needs correcting and we'll update this profile.